Plasma chromogranin A in incidental non-functioning, benign, solid adrenocortical tumors.

Area of Science:

• Endocrinology
• Oncology
• Biochemistry

Background:

• Adrenocortical adenomas are common tumors of the adrenal cortex.
• Chromogranin A (CgA) is a protein found in neuroendocrine cells and is often used as a tumor marker.
• The role of CgA in adrenocortical adenomas is not well understood.

Purpose of the Study:

• To investigate the association between adrenocortical adenomas and elevated CgA levels.
• To determine if CgA expression in adenoma tissue indicates neuroendocrine differentiation.
• To assess if high CgA levels are a marker for malignant transformation of adrenocortical adenomas.

Main Methods:

• Plasma CgA levels were measured in 80 patients with adrenocortical adenomas and 137 healthy controls.
• Immunohistochemistry was used to detect CgA in adrenal tissue specimens.
• CgA levels were reassessed post-surgery in 15 patients and followed clinically and radiologically in others.

Main Results:

• Patients with adrenocortical adenomas had significantly higher plasma CgA levels compared to controls (83.4 vs. 43.1 ng/ml).
• 25% of patients with adenomas had high CgA levels, versus 0.7% in controls.
• CgA immunoreactivity was absent in adenoma tissues, and CgA levels did not change after surgery.
• No signs of malignant transformation were observed during follow-up.

Conclusions:

• Adrenocortical adenomas are strongly associated with elevated plasma CgA levels.
• The elevated CgA is not secreted by the adenoma tissue and does not indicate neuroendocrine differentiation.
• High CgA levels do not serve as a marker for malignant transformation in adrenocortical adenomas.